Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria L Garcia

Showing results (51-60 of 122) with videos related to

Pageof 13
Sort By:
The Journal of Biological Chemistry|May 14, 2005
A variable residue in the pore of Kv1 channels is critical for the high affinity of blockers from sea anemones and scorpionsBernard Gilquin, Sandrine Braud, Mats A L Eriksson, et al.
International Journal of Pharmaceutics|June 21, 2022
Customized cationic nanoemulsions loading triamcinolone acetonide for corneal neovascularization secondary to inflammatory processesAna R Fernandes, Lorena B Vidal, Elena Sánchez-López, et al.
American Journal of Respiratory and Critical Care Medicine|July 27, 2019
Systemic Amyloidosis Mimicking Lung CancerAdam S Fisch, Florian J Fintelmann, Maria L Garcia-Moliner, et al.
Journal of Magnetic Resonance Imaging : JMRI|August 30, 2014
Characteristic time courses of cortical and medullary sodium signals measured by noninvasive (23) Na-MRI in rat kidney induced by furosemideHaiying Liu, Dan Zhou, Maria L Garcia, et al.
Pathogens (Basel, Switzerland)|August 4, 2019
Therapeutic Interventions for Countering Leishmaniasis and Chagas's Disease: From Traditional Sources to Nanotechnological SystemsEliana B Souto, João Dias-Ferreira, Sara A Craveiro, et al.
Assay and Drug Development Technologies|December 17, 2010
A pharmacologically validated, high-capacity, functional thallium flux assay for the human Ether-à-go-go related gene potassium channelWilliam A Schmalhofer, Andrew M Swensen, Brande S Thomas, et al.
Trends in Molecular Medicine|December 23, 2015
The 'Omics' of Amyotrophic Lateral SclerosisDiana Caballero-Hernandez, Miguel G Toscano, Marta Cejudo-Guillen, et al.
International Journal of Pharmaceutics|February 28, 2016
Biopharmaceutical evaluation of epigallocatechin gallate-loaded cationic lipid nanoparticles (EGCG-LNs): In vivo, in vitro and ex vivo studiesJoana F Fangueiro, Ana C Calpena, Beatriz Clares, et al.
Assay and Drug Development Technologies|May 13, 2008
A high-capacity membrane potential FRET-based assay for the sodium-coupled glucose co-transporter SGLT1Adam B Weinglass, Andrew M Swensen, Jessica Liu, et al.
Molecular Pharmacology|August 30, 2008
ProTx-II, a selective inhibitor of NaV1.7 sodium channels, blocks action potential propagation in nociceptorsWilliam A Schmalhofer, Jeffrey Calhoun, Rachel Burrows, et al.
Pageof 13

Showing results (51-60 of 122) with videos related to

Sort By:
Pageof 13
The Journal of Biological Chemistry|May 14, 2005
A variable residue in the pore of Kv1 channels is critical for the high affinity of blockers from sea anemones and scorpionsBernard Gilquin, Sandrine Braud, Mats A L Eriksson, et al.
International Journal of Pharmaceutics|June 21, 2022
Customized cationic nanoemulsions loading triamcinolone acetonide for corneal neovascularization secondary to inflammatory processesAna R Fernandes, Lorena B Vidal, Elena Sánchez-López, et al.
American Journal of Respiratory and Critical Care Medicine|July 27, 2019
Systemic Amyloidosis Mimicking Lung CancerAdam S Fisch, Florian J Fintelmann, Maria L Garcia-Moliner, et al.
Journal of Magnetic Resonance Imaging : JMRI|August 30, 2014
Characteristic time courses of cortical and medullary sodium signals measured by noninvasive (23) Na-MRI in rat kidney induced by furosemideHaiying Liu, Dan Zhou, Maria L Garcia, et al.
Pathogens (Basel, Switzerland)|August 4, 2019
Therapeutic Interventions for Countering Leishmaniasis and Chagas's Disease: From Traditional Sources to Nanotechnological SystemsEliana B Souto, João Dias-Ferreira, Sara A Craveiro, et al.
Assay and Drug Development Technologies|December 17, 2010
A pharmacologically validated, high-capacity, functional thallium flux assay for the human Ether-à-go-go related gene potassium channelWilliam A Schmalhofer, Andrew M Swensen, Brande S Thomas, et al.
Trends in Molecular Medicine|December 23, 2015
The 'Omics' of Amyotrophic Lateral SclerosisDiana Caballero-Hernandez, Miguel G Toscano, Marta Cejudo-Guillen, et al.
International Journal of Pharmaceutics|February 28, 2016
Biopharmaceutical evaluation of epigallocatechin gallate-loaded cationic lipid nanoparticles (EGCG-LNs): In vivo, in vitro and ex vivo studiesJoana F Fangueiro, Ana C Calpena, Beatriz Clares, et al.
Assay and Drug Development Technologies|May 13, 2008
A high-capacity membrane potential FRET-based assay for the sodium-coupled glucose co-transporter SGLT1Adam B Weinglass, Andrew M Swensen, Jessica Liu, et al.
Molecular Pharmacology|August 30, 2008
ProTx-II, a selective inhibitor of NaV1.7 sodium channels, blocks action potential propagation in nociceptorsWilliam A Schmalhofer, Jeffrey Calhoun, Rachel Burrows, et al.
Pageof 13